AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Free cash flow
AtriCure, Inc.'s free cash flow for fiscal 2025 was $48.3M, up 6,170.6% from $770.0K in fiscal 2024. Over the twelve months to 30 September 2026 it was $52.9M. Over the past ten years it has ranged from −$39.0M (fiscal 2022) to $48.3M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. AtriCure, Inc. ranks 21st of 51 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $48.3M | 6,170.65% |
| FY2024 | $770.0K | — |
| FY2023 | −$7.5M | — |
| FY2022 | −$39.0M | — |
| FY2021 | −$23.5M | — |
| FY2020 | −$25.1M | — |
| FY2019 | −$28.0M | — |
| FY2018 | −$10.4M | — |
| FY2017 | −$15.3M | — |
| FY2016 | −$22.8M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $23.9M | 29.89% |
| Jun 2026 | $18.4M | — |
| Mar 2026 | −$7.8M | — |
| Dec 2025 | $18.4M | (23.58%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| ICUI ICU Medical, Inc. compare | $272.2M |
| XRAY DENTSPLY SIRONA Inc. compare | $272.0M |
| NVST Envista Holdings Corporation compare | $244.6M |
| MMSI Merit Medical Systems, Inc. compare | $225.8M |
| ATRC AtriCure, Inc. | $52.9M |
| WRBY Warby Parker Inc. compare | $21.3M |
| STVN Stevanato Group S.p.A. compare | −$8.8M |
| PLSE Pulse Biosciences, Inc compare | −$216.1M |
| MMED MiniMed Group, Inc. compare | −$452.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement